• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

我们能否在 OLS 和受污染的 IV 方法之间做出明智的选择?

Can we make smart choices between OLS and contaminated IV methods?

机构信息

Departments of Health Services, Pharmacy and Economics, University of Washington, Seattle, WA, USA; The National Bureau of Economic Research, Cambridge, MA, USA.

出版信息

Health Econ. 2014 Apr;23(4):462-72. doi: 10.1002/hec.2926. Epub 2013 Jun 13.

DOI:10.1002/hec.2926
PMID:23765683
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4282844/
Abstract

In the outcomes research and comparative effectiveness research literature, there are strong cautionary tales on the use of instrumental variables (IVs) that may influence the newly initiated to shun this premier tool for casual inference without properly weighing their advantages. It has been recommended that IV methods should be avoided if the instrument is not econometrically perfect. The fact that IVs can produce better results than naïve regression, even in nonideal circumstances, remains underappreciated. In this paper, we propose a diagnostic criterion and related software that can be used by an applied researcher to determine the plausible superiority of IV over an ordinary least squares (OLS) estimator, which does not address the endogeneity of a covariate in question. Given a reasonable lower bound for the bias arising out of an OLS estimator, the researcher can use our proposed diagnostic tool to confirm whether the IV at hand can produce a better estimate (i.e., with lower mean square error) of the true effect parameter than the OLS, without knowing the true level of contamination in the IV.

摘要

在结局研究和比较效果研究文献中,有很多关于工具变量(IV)使用的警示故事,这可能会导致新学者回避这种用于因果推断的主要工具,而不恰当地权衡其优势。有人建议,如果工具变量在计量经济学上并不完美,就应该避免使用 IV 方法。IV 即使在不理想的情况下也能产生比简单回归更好的结果,这一点仍未得到充分认识。在本文中,我们提出了一种诊断标准和相关软件,应用研究人员可以使用这些标准和软件来确定 IV 是否优于普通最小二乘法(OLS)估计量,而后者不能解决所讨论的协变量的内生性问题。给定 OLS 估计量产生偏差的合理下限,研究人员可以使用我们提出的诊断工具来确认手头的 IV 是否可以比 OLS 产生更好的真实效应参数估计(即均方误差更低),而无需了解 IV 的真实污染水平。

相似文献

1
Can we make smart choices between OLS and contaminated IV methods?我们能否在 OLS 和受污染的 IV 方法之间做出明智的选择?
Health Econ. 2014 Apr;23(4):462-72. doi: 10.1002/hec.2926. Epub 2013 Jun 13.
2
Some cautions on the use of instrumental variables estimators in outcomes research: how bias in instrumental variables estimators is affected by instrument strength, instrument contamination, and sample size.在结果研究中使用工具变量估计器时的一些注意事项:工具变量估计器的偏差如何受到工具强度、工具污染和样本量的影响。
Value Health. 2011 Dec;14(8):1078-84. doi: 10.1016/j.jval.2011.06.009. Epub 2011 Oct 1.
3
Bias testing, bias correction, and confounder selection using an instrumental variable model.使用工具变量模型进行偏差测试、偏差校正和混杂因素选择。
Stat Med. 2020 Dec 20;39(29):4386-4404. doi: 10.1002/sim.8730. Epub 2020 Aug 27.
4
Sample size importantly limits the usefulness of instrumental variable methods, depending on instrument strength and level of confounding.样本量对工具变量法的有用性有重要影响,这取决于工具的强度和混杂程度。
J Clin Epidemiol. 2014 Nov;67(11):1258-64. doi: 10.1016/j.jclinepi.2014.05.019. Epub 2014 Aug 12.
5
Instrumental variables vs. grouping approach for reducing bias due to measurement error.用于减少测量误差导致的偏差的工具变量法与分组法
Int J Biostat. 2008;4(1):Article 8. doi: 10.2202/1557-4679.1087.
6
Dose-response modeling in mental health using stein-like estimators with instrumental variables.使用带工具变量的类斯坦估计器进行心理健康中的剂量反应建模。
Stat Med. 2017 May 20;36(11):1696-1714. doi: 10.1002/sim.7265. Epub 2017 Feb 21.
7
Evaluating disease management programme effectiveness: an introduction to instrumental variables.评估疾病管理项目的有效性:工具变量介绍
J Eval Clin Pract. 2006 Apr;12(2):148-54. doi: 10.1111/j.1365-2753.2006.00615.x.
8
Use and misuse of the reduced major axis for line-fitting.回归线拟合的正确与错误使用方法。
Am J Phys Anthropol. 2009 Nov;140(3):476-86. doi: 10.1002/ajpa.21090.
9
An exploratory instrumental variable analysis of the outcomes of localized breast cancer treatments in a medicare population.对医疗保险人群中局部乳腺癌治疗结果的探索性工具变量分析。
Health Econ. 2003 Mar;12(3):171-86. doi: 10.1002/hec.710.
10
A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment.精神分裂症治疗资源消耗分析中处理偏态分布成本变量方法的比较。
J Ment Health Policy Econ. 2002 Mar;5(1):21-31.

引用本文的文献

1
Effect of Health Literacy on Antiviral Treatment of Hepatitis B: Instrumental Variable Analysis.健康素养对乙型肝炎抗病毒治疗的影响:工具变量分析
JMIR Public Health Surveill. 2024 Dec 16;10:e58391. doi: 10.2196/58391.
2
Effectiveness of Gastric Bypass Versus Gastric Sleeve for Cardiovascular Disease: Protocol and Baseline Results for a Comparative Effectiveness Study.胃旁路手术与胃袖状切除术治疗心血管疾病的有效性:一项比较有效性研究的方案和基线结果
JMIR Res Protoc. 2020 Apr 6;9(4):e14936. doi: 10.2196/14936.
3
Health Care Utilization and Treatment Persistence Associated with Oral Paliperidone and Lurasidone in Schizophrenia Treatment.

本文引用的文献

1
Some cautions on the use of instrumental variables estimators in outcomes research: how bias in instrumental variables estimators is affected by instrument strength, instrument contamination, and sample size.在结果研究中使用工具变量估计器时的一些注意事项:工具变量估计器的偏差如何受到工具强度、工具污染和样本量的影响。
Value Health. 2011 Dec;14(8):1078-84. doi: 10.1016/j.jval.2011.06.009. Epub 2011 Oct 1.
2
Efficacy of phototherapy for newborns with hyperbilirubinemia: a cautionary example of an instrumental variable analysis.光疗治疗新生儿高胆红素血症的疗效:工具变量分析的一个警示性实例。
Med Decis Making. 2012 Jan-Feb;32(1):83-92. doi: 10.1177/0272989X11416512. Epub 2011 Aug 21.
3
精神分裂症治疗中口服帕利哌酮和鲁拉西酮与医疗保健利用和治疗持续性的关系。
J Manag Care Spec Pharm. 2015 Sep;21(9):780-92. doi: 10.18553/jmcp.2015.21.9.780.
4
Instrumental variable methods for causal inference.工具变量法在因果推断中的应用。
Stat Med. 2014 Jun 15;33(13):2297-340. doi: 10.1002/sim.6128. Epub 2014 Mar 6.
Preference-based instrumental variable methods for the estimation of treatment effects: assessing validity and interpreting results.
用于估计治疗效果的基于偏好的工具变量方法:评估有效性与解释结果
Int J Biostat. 2007;3(1):Article 14. doi: 10.2202/1557-4679.1072.
4
When and how to use instrumental variables in palliative care research.何时以及如何在姑息治疗研究中使用工具变量。
J Palliat Med. 2009 May;12(5):471-4. doi: 10.1089/jpm.2009.9631.
5
Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling.两阶段残差包含估计:解决健康计量经济学建模中的内生性问题
J Health Econ. 2008 May;27(3):531-43. doi: 10.1016/j.jhealeco.2007.09.009. Epub 2007 Dec 4.
6
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.抗精神病药物对慢性精神分裂症患者的疗效。
N Engl J Med. 2005 Sep 22;353(12):1209-23. doi: 10.1056/NEJMoa051688. Epub 2005 Sep 19.
7
Economic outcomes associated with olanzapine versus risperidone in the treatment of uncontrolled schizophrenia.奥氮平与利培酮治疗难治性精神分裂症的经济结果。
Curr Med Res Opin. 2004 Jul;20(7):1039-48. doi: 10.1185/030079904125004097.
8
Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.氯氮平、奥氮平、利培酮及氟哌啶醇治疗慢性精神分裂症和分裂情感性障碍患者
Am J Psychiatry. 2002 Feb;159(2):255-62. doi: 10.1176/appi.ajp.159.2.255.
9
Olanzapine versus risperidone. A prospective comparison of clinical and economic outcomes in schizophrenia.奥氮平与利培酮:精神分裂症临床及经济结局的前瞻性比较
Pharmacoeconomics. 2000 Dec;18(6):567-79. doi: 10.2165/00019053-200018060-00004.